Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Psoriatic Arthritis (PsA) Treatment Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Status and Forecast (2016-2027)
      • 1.3.2 Global Psoriatic Arthritis (PsA) Treatment Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Psoriatic Arthritis (PsA) Treatment Supply by Company

    • 2.1 Global Psoriatic Arthritis (PsA) Treatment Sales Value by Company
    • 2.2 Psoriatic Arthritis (PsA) Treatment Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Psoriatic Arthritis (PsA) Treatment Market Status by Category

    • 3.1 Psoriatic Arthritis (PsA) Treatment Category Introduction
      • 3.1.1 Nonsteriodal Anti-inflammatory Drugs
      • 3.1.2 Disease Modifying Antirheumatic Drugs
      • 3.1.3 Biologics
    • 3.2 Global Psoriatic Arthritis (PsA) Treatment Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Psoriatic Arthritis (PsA) Treatment Market Status by End User/Segment

    • 4.1 Psoriatic Arthritis (PsA) Treatment Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Others
    • 4.2 Global Psoriatic Arthritis (PsA) Treatment Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Psoriatic Arthritis (PsA) Treatment Market Status by Region

    • 5.1 Global Psoriatic Arthritis (PsA) Treatment Market by Region
    • 5.2 North America Psoriatic Arthritis (PsA) Treatment Market Status
    • 5.3 Europe Psoriatic Arthritis (PsA) Treatment Market Status
    • 5.4 Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Status
    • 5.5 Central & South America Psoriatic Arthritis (PsA) Treatment Market Status
    • 5.6 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Status

    6 North America Psoriatic Arthritis (PsA) Treatment Market Status

    • 6.1 North America Psoriatic Arthritis (PsA) Treatment Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Psoriatic Arthritis (PsA) Treatment Market Status

    • 7.1 Europe Psoriatic Arthritis (PsA) Treatment Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Status

    • 8.1 Asia Pacific Psoriatic Arthritis (PsA) Treatment Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Psoriatic Arthritis (PsA) Treatment Market Status

    • 9.1 Central & South America Psoriatic Arthritis (PsA) Treatment Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Status

    • 10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Category and by End User/Segment

    • 12.1 Global Psoriatic Arthritis (PsA) Treatment Sales Value Forecast (2022-2027)
    • 12.2 Global Psoriatic Arthritis (PsA) Treatment Forecast by Category
    • 12.3 Global Psoriatic Arthritis (PsA) Treatment Forecast by End User/Segment

    13 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Region/Country

    • 13.1 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 UCB
      • 14.1.1 Company Information
      • 14.1.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.1.3 UCB Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Roche
      • 14.2.1 Company Information
      • 14.2.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.2.3 Roche Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer
      • 14.3.1 Company Information
      • 14.3.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.3.3 Pfizer Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Novartis
      • 14.4.1 Company Information
      • 14.4.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Johnson & Johnson
      • 14.5.1 Company Information
      • 14.5.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.5.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Eli Lilly
      • 14.6.1 Company Information
      • 14.6.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.6.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Celgene
      • 14.7.1 Company Information
      • 14.7.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.7.3 Celgene Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bristol-Myers Squibb
      • 14.8.1 Company Information
      • 14.8.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.8.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 AstraZeneca
      • 14.9.1 Company Information
      • 14.9.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.9.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Amgen
      • 14.10.1 Company Information
      • 14.10.2 Psoriatic Arthritis (PsA) Treatment Product Introduction
      • 14.10.3 Amgen Psoriatic Arthritis (PsA) Treatment Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 AbbVie

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Psoriatic Arthritis (PsA) Treatment market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Psoriatic Arthritis (PsA) Treatment market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Nonsteriodal Anti-inflammatory Drugs
      Disease Modifying Antirheumatic Drugs
      Biologics

      Segmented by End User/Segment
      Hospitals
      Clinics
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      UCB
      Roche
      Pfizer
      Novartis
      Johnson & Johnson
      Eli Lilly
      Celgene
      Bristol-Myers Squibb
      AstraZeneca
      Amgen
      AbbVie
      Buy now